TNPSC Thervupettagam

Vaccine Development in India

May 31 , 2020 1560 days 874 0
  • The Centre for Cellular and Molecular Biology (CCMB) has established stable cultures of COVID-19 (SARS-CoV-2) from the samples of the patients. 
  • CCMB Virologists isolated infectious viruses from several isolates.
  • The ability to culture the virus in the lab will enable the virologists at CCMB to work towards the drug testing and vaccine development to fight COVID-19.
  • If a large amount of virus is cultured and inactivated, it can be used as an inactivated virus vaccine. 
  • Once the inactivated virus is injected, the human immune system will start triggering the production of germ-specific antibodies.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories